Abstract
Background Vitamin D regulates intestinal epithelial and immune functions, and vitamin D receptor deficiency increases the severity of murine colitis. Bioavailable 25-hydroxyvitamin D (25(OH)D) is available to target tissues and may be a driver of immune function. The aim is to evaluate the relationship of bioavailable 25(OH)D to the clinical expression of treatment naive pediatric ulcerative colitis (UC). Methods The PROTECT (Predicting Response to Standardized Pediatric Colitis Therapy) study enrolled children ≤17 years newly diagnosed with UC. Free and total 25(OH)D were directly measured and 25(OH)D fractions were compared with disease activity measures. Results Data were available on 388 subjects, mean age 12.7 years, 49% female, 84% with extensive/pancolitis. The median (IQR) total 25(OH)D concentration was 28.5 (23.9, 34.8) ng/mL, and 57% of subjects demonstrated insufficient vitamin D status (25(OH)D < 30 ng/mL). We found no evidence of association between total 25(OH)D and disease activity. Regression models adjusted for age, sex, race, and ethnicity demonstrated that an increase from 25 th to 75 th percentile for bioavailable and free 25(OH)D were associated with a mean (95 th CI) decrease in the Pediatric Ulcerative Colitis Activity Index (PUCAI) of -8.7 (-13.7, -3.6) and -3.1 (-5.0, -1.2), respectively. No associations were detected between 25(OH)D fractions and fecal calprotectin or Mayo endoscopy score. Conclusions Vitamin D insufficiency is highly prevalent in children with newly diagnosed UC. We found associations of free and bioavailable, but not total 25(OH)D, with PUCAI. Bioavailable vitamin D may contribute to UC pathophysiology and clinical activity.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 641-650 |
| Number of pages | 10 |
| Journal | Inflammatory bowel diseases |
| Volume | 24 |
| Issue number | 3 |
| DOIs | |
| State | Published - Feb 16 2018 |
| Externally published | Yes |
Fingerprint
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Gastroenterology
Cite this
}
Free and bioavailable 25-hydroxyvitamin D concentrations are associated with disease activity in pediatric patients with newly diagnosed treatment naive ulcerative colitis. / Sauer, Cary G.; Loop, Matthew S.; Venkateswaran, Suresh; Tangpricha, Vin; Ziegler, Thomas R.; Dhawan, Ashish; McCall, Courtney; Bonkowski, Erin; Mack, David R.; Boyle, Brendan; Griffiths, Anne M.; Leleiko, Neal S.; Keljo, David J.; Markowitz, James; Baker, Susan S.; Rosh, Joel; Baldassano, Robert N.; Davis, Sonia; Patel, Shiven; Wang, Jessie; Marquis, Alison; Spada, Krista L.; Kugathasan, Subra; Walters, Thomas; Hyams, Jeffrey S.; Denson, Lee A.
In: Inflammatory bowel diseases, Vol. 24, No. 3, 16.02.2018, p. 641-650.Research output: Contribution to journal › Article
TY - JOUR
T1 - Free and bioavailable 25-hydroxyvitamin D concentrations are associated with disease activity in pediatric patients with newly diagnosed treatment naive ulcerative colitis
AU - Sauer, Cary G.
AU - Loop, Matthew S.
AU - Venkateswaran, Suresh
AU - Tangpricha, Vin
AU - Ziegler, Thomas R.
AU - Dhawan, Ashish
AU - McCall, Courtney
AU - Bonkowski, Erin
AU - Mack, David R.
AU - Boyle, Brendan
AU - Griffiths, Anne M.
AU - Leleiko, Neal S.
AU - Keljo, David J.
AU - Markowitz, James
AU - Baker, Susan S.
AU - Rosh, Joel
AU - Baldassano, Robert N.
AU - Davis, Sonia
AU - Patel, Shiven
AU - Wang, Jessie
AU - Marquis, Alison
AU - Spada, Krista L.
AU - Kugathasan, Subra
AU - Walters, Thomas
AU - Hyams, Jeffrey S.
AU - Denson, Lee A.
PY - 2018/2/16
Y1 - 2018/2/16
N2 - Background Vitamin D regulates intestinal epithelial and immune functions, and vitamin D receptor deficiency increases the severity of murine colitis. Bioavailable 25-hydroxyvitamin D (25(OH)D) is available to target tissues and may be a driver of immune function. The aim is to evaluate the relationship of bioavailable 25(OH)D to the clinical expression of treatment naive pediatric ulcerative colitis (UC). Methods The PROTECT (Predicting Response to Standardized Pediatric Colitis Therapy) study enrolled children ≤17 years newly diagnosed with UC. Free and total 25(OH)D were directly measured and 25(OH)D fractions were compared with disease activity measures. Results Data were available on 388 subjects, mean age 12.7 years, 49% female, 84% with extensive/pancolitis. The median (IQR) total 25(OH)D concentration was 28.5 (23.9, 34.8) ng/mL, and 57% of subjects demonstrated insufficient vitamin D status (25(OH)D < 30 ng/mL). We found no evidence of association between total 25(OH)D and disease activity. Regression models adjusted for age, sex, race, and ethnicity demonstrated that an increase from 25 th to 75 th percentile for bioavailable and free 25(OH)D were associated with a mean (95 th CI) decrease in the Pediatric Ulcerative Colitis Activity Index (PUCAI) of -8.7 (-13.7, -3.6) and -3.1 (-5.0, -1.2), respectively. No associations were detected between 25(OH)D fractions and fecal calprotectin or Mayo endoscopy score. Conclusions Vitamin D insufficiency is highly prevalent in children with newly diagnosed UC. We found associations of free and bioavailable, but not total 25(OH)D, with PUCAI. Bioavailable vitamin D may contribute to UC pathophysiology and clinical activity.
AB - Background Vitamin D regulates intestinal epithelial and immune functions, and vitamin D receptor deficiency increases the severity of murine colitis. Bioavailable 25-hydroxyvitamin D (25(OH)D) is available to target tissues and may be a driver of immune function. The aim is to evaluate the relationship of bioavailable 25(OH)D to the clinical expression of treatment naive pediatric ulcerative colitis (UC). Methods The PROTECT (Predicting Response to Standardized Pediatric Colitis Therapy) study enrolled children ≤17 years newly diagnosed with UC. Free and total 25(OH)D were directly measured and 25(OH)D fractions were compared with disease activity measures. Results Data were available on 388 subjects, mean age 12.7 years, 49% female, 84% with extensive/pancolitis. The median (IQR) total 25(OH)D concentration was 28.5 (23.9, 34.8) ng/mL, and 57% of subjects demonstrated insufficient vitamin D status (25(OH)D < 30 ng/mL). We found no evidence of association between total 25(OH)D and disease activity. Regression models adjusted for age, sex, race, and ethnicity demonstrated that an increase from 25 th to 75 th percentile for bioavailable and free 25(OH)D were associated with a mean (95 th CI) decrease in the Pediatric Ulcerative Colitis Activity Index (PUCAI) of -8.7 (-13.7, -3.6) and -3.1 (-5.0, -1.2), respectively. No associations were detected between 25(OH)D fractions and fecal calprotectin or Mayo endoscopy score. Conclusions Vitamin D insufficiency is highly prevalent in children with newly diagnosed UC. We found associations of free and bioavailable, but not total 25(OH)D, with PUCAI. Bioavailable vitamin D may contribute to UC pathophysiology and clinical activity.
UR - http://www.scopus.com/inward/record.url?scp=85050248447&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050248447&partnerID=8YFLogxK
U2 - 10.1093/ibd/izx052
DO - 10.1093/ibd/izx052
M3 - Article
C2 - 29462384
AN - SCOPUS:85050248447
VL - 24
SP - 641
EP - 650
JO - Inflammatory Bowel Diseases
JF - Inflammatory Bowel Diseases
SN - 1078-0998
IS - 3
ER -